Document ID: chunk:federal_register_of_legislation:F2017L00081:reg:10:p4
Version: federal_register_of_legislation:F2017L00081
Segment Type: reg
Provision Reference: reg 10 (pt 4/6)
Character Range: 40280–44577

(CAS 53159–39–0);
 (13) polynitrorthocarbonates;
 (14) FPF–1 (poly‑2,2,3,3,4,4‑hexafluoro pentane‑1,5‑diolformal) (CAS 376–90–9);
 (15) FPF–3 (poly‑2,4,4,5,5,6,6‑heptafluoro‑2‑trifluoromethyl‑3‑oxaheptane‑1,7‑diolformal);
 (16) PGN (Polyglycidylnitrate or poly(nitratomethyl oxirane); poly‑GLYN); (CAS 27814–48–8);
 (17) N‑methyl‑p‑nitroaniline (MT);
 (18) low (less than 10,000) molecular weight, alcohol‑functionalised, poly(epichlorohydrin); poly(epichlorohydrindiol); and triol;
 (19) dinitropropyl based plasticisers, as follows (MT):
 (i) BDNPA (bis (2,2‑dinitropropyl) acetal) (CAS 5108‑69‑0);
 (ii) BDNPF (bis (2,2‑dinitropropyl) formal) (CAS 5917‑61‑3).
 (f) Additives, as follows:
 (1) basic copper salicylate (CAS 62320–94–9);
 (2) BHEGA (Bis‑(2‑hydroxyethyl)glycolamide) (CAS 17409–41–5);
 (3) BNO (Butadienenitrile oxide);
 (4) ferrocene derivatives, as follows (MT):
 (i) butacene (CAS 125856–62–4);
 (ii) catocene (2,2‑Bis‑ethylferrocenyl propane) (CAS 37206–42–1);
 (iii) ferrocene carboxylic acids and ferrocene carboxylic acid esters;
 (iv) n‑butylferrocene (CAS 31904–29–7);
 (v) ethylferrocene (CAS 1273‑89‑8);
 (vi) propylferrocene;
 (vii) pentylferrocene (CAS 1274‑00‑6);
 (viii) dicyclopentylferrocene;
 (ix) dicyclohexylferrocene;
 (x) diethylferrocene (CAS 173‑97‑8);
 (xi) dipropylferrocene;
 (xii) dibutylferrocene (CAS 1274‑08‑4);
 (xiii) dihexylferrocene (CAS 93894‑59‑8);
 (xiv) acetylferrocene (CAS 1271‑55‑2)/1,1′‑diacetyl ferrocene (CAS 1273‑94‑5);
 (xv) other ferrocene derivatives that do not contain a six carbon aromatic functional group attached to the ferrocene molecule (MT if usable as rocket propellant burning rate modifier);
 (5) lead beta‑resorcylate (CAS 20936–32–7);
 (6) lead citrate (CAS 14450–60–3);
 (7) lead‑copper chelates of beta‑resorcylate or salicylates (CAS 68411–07–4);
 (8) lead maleate (CAS 19136–34–6);
 (9) lead salicylate (CAS 15748–73–9);
 (10) lead stannate (CAS 12036–31–6);
 (11) MAPO (tris‑1‑(2‑methyl)aziridinyl phosphine oxide) (CAS 57–39–6); BOBBA–8 (bis(2‑methyl aziridinyl) 2‑(2‑hydroxypropanoxy) propylamino phosphine oxide); and other MAPO derivatives (MT for MAPO);
 (12) methyl BAPO (Bis(2‑methyl aziridinyl) methylamino phosphine oxide) (CAS 85068–72–0);
 (13) 3‑Nitraza‑1,5 pentane diisocyanate (CAS 7406–61–9);
 (14) organo‑metallic coupling agents, as follows:
 (i) neopentyl[diallyl]oxy, tri [dioctyl] phosphatotitanate (CAS 103850–22–2); also known as titanium IV, 2,2[bis 2‑propenolato‑methyl, butanolato, tris (dioctyl) phosphato] (CAS 110438–25–0), or LICA 12 (CAS 103850–22–2);
 (ii) titanium IV, [(2‑propenolato‑1) methyl, n‑propanolatomethyl] butanolato‑1, tris(dioctyl)pyrophosphate, or KR3538;
 (iii) titanium IV, [2‑propenolato‑1)methyl, propanolatomethyl] butanolato‑1, tris(dioctyl) phosphate;
 (15) PCDE (Polycyanodifluoroaminoethylene oxide);
 (16) certain bonding agents, as follows (MT):
 (i) 1,1R,1S‑trimesoyl‑tris(2‑ethylaziridine) (HX‑868, BITA) (CAS 7722‑73‑8);
 (ii) polyfunctional aziridine amides with isophthalic, trimesic, isocyanuric, or trimethyladipic backbone also having a 2‑methyl or 2‑ethyl aziridine group;
 (17) superfine iron oxide (Fe2O3, hematite) with a specific surface area more than 250 m2/g and an average particle size of 0.003 micrometres or less (CAS 1309–37–1);
 (18) TEPAN (HX‑879) (tetraethylenepentaamineacrylonitrile) (CAS 68412–45–3); cyanoethylated polyamines and their salts (MT for TEPAN (HX‑879);
 (19) TEPANOL (HX‑878) (Tetraethylenepentaamineacrylo‑nitrileglycidol) (CAS 68412–46–4); cyanoethylated polyamines adducted with glycidol and their salts (MT for TEPANOL (HX‑878);
 (20) TPB (triphenyl bismuth) (CAS 603–33–8) (MT);
 (21) Tris (ethoxyphenyl) bismuth (TEPB) (CAS 90591‑48‑3).
Note: Subsubparagraph (16)(ii)—included are:
(a) 1,1H‑Isophthaloyl‑bis(2‑methylaziridine) (HX‑752) (CAS 7652‑64‑4); and
(b) 2,4,6‑tris(2‑ethyl‑1‑aziridinyl)‑1,3,5‑triazine (HX‑874) (CAS 18924‑91‑9); and
(c) 1,1′‑trimethyladipoylbis(2‑ethylaziridine) (HX‑877) (CAS 71463‑62‑2).
 (g) Precursors, as follows:
 (1) BCMO (3‑3‑bis(chloromethyl)oxetane) (CAS 78–71–7);
 (2) DADN (1,5‑diacetyl‑3,7‑dinitro‑1, 3, 5, 7‑tetraazacyclooctane);
 (3) dinitroazetidine‑t‑butyl salt (CAS 125735–38–8);
 (4) CL‑20 precursors (any molecule containing hexaazaisowurtzitane) (for example, HBIW